+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Active Pharmaceutical Ingredients Market, by Manufacturer, by Synthesis, by Drug, by Therapeutic, by Region; Trend Analysis, Competitive Market Share & Forecast, 2015-2025

  • PDF Icon


  • 125 Pages
  • September 2019
  • Region: Global
  • Blueweave Consulting & Research Pvt Ltd
  • ID: 4855426
The Active Pharmaceutical Ingredient Market is anticipated to reach US$ 257,891 Million by 2025 with a significant CAGR of 5.97% in the forecast period of 2015-25. Price is one of the growth driving factor for generic drug adoption in the forecast period of 2019-25, in comparison with brand name analogue the prices of generic drugs are cheaper with the same standards followed by innovator drugs such as safety, efficacy, and quality. Significant growth in prevalence of cardiovascular, chronic and infectious diseases coupled with an increasing pattern of an unhealthy lifestyle and growing geriatric population enhance the demand of generic drug market (in terms of sales) in the developing countries. Emerging economies such as India and China, as manufacturers have sufficient manufacturing units, a higher spending power, and greater significance on transparent pricing by measuring effects on the population to expand the pattern of generic adoption and generic drug manufacturing in the global active pharmaceutical ingredient market (2019-25).

In terms of therapeutic area oncology segment is anticipated to drive the global generic medicine in active pharmaceutical ingredient market due to the lucrative number of research, in-process research, and patent expiry in the oncology segment. Regulated policy and reforms by the United States to regulate the healthcare affordability coupled with the biotech synthesis of innovative drugs and technology anticipated to propel the growth of generic drug adoption in the active pharmaceutical ingredient market.

Captive (In-house) manufacturing holds the largest market share of active pharmaceutical ingredient market in the forecast period

To uphold in the highly competitive landscape, the upcoming players are investing in innovative product launches with in-process R&D. Economic benefits and prevent technology leakage followed by the trend of maintaining active pharmaceutical ingredient manufacturing with the integration in pharmaceutical supply chain propel the growth of captive (In-house) manufacturers in the forecast period. The major advantages of active manufacturing are flexibility, customisation, rapid testing of prototypes, and lower cost when producing in small volumes. The significant growth rate in spending of healthcare is one the factor driving the growth of captive manufacturing in active pharmaceutical ingredient market during the forecast period of 2019-25.

Growing demand for CVD drugs is the growth driven factor for active pharmaceutical ingredient market during the forecast period

The Active Pharmaceutical Ingredient market is getting a boost from the growing prevalence of cardiovascular, chronic, and infectious diseases coupled with the increasing trend of an unhealthy lifestyle and growing geriatric population. CVD is emerging as the lucrative therapeutic segment for innovative and generic drug manufacturing companies in terms of CVD drug consumption by end-users in the forecast duration. Increasing adoption rate of generic medicine in the developing countries drive the global medical spending in generic drug segment. Increasing demand for low-cost CVD generic drug market is anticipated to witness a lucrative growth rate in the forecast period of 2019-25.

Active pharmaceutical ingredient Market: Competitive Landscape

Some of the major industry players are Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sun Pharmaceutical Industries Ltd., Pfizer Inc., Aurobindo Pharma, Abbott Laboratories, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Novartis AG, Hoffmann-La Roche Ltd, Bayer AG and Other Prominent Players.

The in-depth analysis of the report provides the growth potential, upcoming trends and statistics of Active pharmaceutical ingredient market size & forecast. The report promises to provide state-of-the-art technology of Active pharmaceutical ingredient production and industry insights which help decision makers to take sound strategic decisions. Furthermore, the report also analyzes the market drivers and challenges and competitive analysis of the market.

This product will be delivered within 2 business days.

Table of Contents

1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Region
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents
2.5. Market Size Estimation
2.6. Assumption for the Study
2.7. Market Breakdown & Data Triangulation
3. Executive Summary
4. Global Active Pharmaceutical Ingredient Industry Insights
4.1. Industry Value Chain Analysis
4.1.1. Vendor Matrix
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Regulatory Framework
4.5. Company market share analysis,2018
4.6. Porter’s Five forces analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of New Entrants
4.6.4. Threat of Substitutes
4.6.5. Intensity of Rivalry
4.7. PESTEL Analysis
4.8. Strategic Outlook
5. Global Active Pharmaceutical Ingredient Market Overview
5.1. Market Size & Forecast 2015-2025
5.1.1. By Value (USD)
5.2. Market Share & Forecast
5.2.1. By Manufacturer Type Captive (In-House) Manufacturer Merchant (Contract) Manufacturer
5.2.2. By Active Pharmaceutical Ingredient Type Synthetic Chemical API Biotech/Biological API Plant Extracts API High-potency API Classical Fermentation API
5.2.3. By Drug Type Branded or Innovative Drug Generic Prescription Drug OTC (over the counter) Drug Other Drug
5.2.4. By Therapeutic Area Anti-Infective Drug Metabolic Disorders Drug Cardiovascular Drug Oncology Drug Central Nervous System Drug Respiratory Drug Other Therapeutic Drug
5.2.5. By Region North America Europe Asia Pacific Latin America Middle East & Africa
6. North America Active Pharmaceutical Ingredient Market
6.1. Key Regional Trends
6.2. Market estimates & forecast
6.2.1. By Manufacturer Type
6.2.2. By Active Pharmaceutical Ingredient Type
6.2.3. By Drug Type
6.2.4. By Therapeutic Area
6.2.5. By Country U.S Canada
7. Europe Active Pharmaceutical Ingredient Market
7.1. Key Regional Trends
7.2. Market estimates & forecast
7.2.1. By Manufacturer Type
7.2.2. By Active Pharmaceutical Ingredient Type
7.2.3. By Drug Type
7.2.4. By Therapeutic Area
7.2.5. By Country Germany U.K France Italy Rest of Europe
8. Asia Pacific Active Pharmaceutical Ingredient Market
8.1. Key Regional Trends
8.2. Market estimates & forecast
8.2.1. By Manufacturer Type
8.2.2. By Active Pharmaceutical Ingredient Type
8.2.3. By Drug Type
8.2.4. By Therapeutic Area
8.2.5. By Country China India Japan Rest of APAC
9. Latin America Active Pharmaceutical Ingredient Market
9.1. Key Regional Trends
9.2. Market estimates & forecast
9.2.1. By Manufacturer Type
9.2.2. By Active Pharmaceutical Ingredient Type
9.2.3. By Drug Type
9.2.4. By Therapeutic Area
9.2.5. By Country Brazil Argentina Rest of Latin America
10. Middle East & Africa Active Pharmaceutical Ingredient Market
10.1. Key Regional Trends
10.2. Market estimates & forecast
10.2.1. By Manufacturer Type
10.2.2. By Active Pharmaceutical Ingredient Type
10.2.3. By Drug Type
10.2.4. By Therapeutic Area
10.2.5. By Country Saudi Arabia UAE South Africa Rest of MEA
11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)*
11.1. Teva Pharmaceutical Industries Ltd.
11.2. Boehringer Ingelheim GmbH
11.3. Sun Pharmaceutical Industries Ltd.
11.4. Pfizer Inc.
11.5. Aurobindo Pharma
11.6. Abbott Laboratories
11.7. Merck & Co., Inc.
11.8. Novartis AG
11.9. Hoffmann-La Roche Ltdss
11.10. Bayer AG
11.11. Other Prominent Players